Conversations

As a participant in the recent forum on Alzheimer’s hosted by PhRMA, the Alzheimer’s Association and Alzheimer’s Drug Discovery Foundation, what do you think are some of the biggest research challenges and opportunities related to the disease?

Contributors Respond

Dr. Bill Chin

Dr. Bill Chin

EVP, Scientific & Regulatory Affairs, PhRMA

Read Dr. Bill Chin's bio

Diane Stephenson, Ph.D.

Diane Stephenson, Ph.D.

EVP, Coalition Against Major Diseases

Read Diane Stephenson, Ph.D. 's bio

Dr. Neill R. Graff-Radford, MRCP

Dr. Neill R. Graff-Radford, MRCP

Neurologist, Mayo Clinic

Read Dr. Neill R. Graff-Radford, MRCP's bio

Paul Howard, Ph.D

Paul Howard, Ph.D

Senior Fellow, Manhattan Institute

Read Paul Howard, Ph.D's bio

Heather Snyder

Heather Snyder

Director, Medical & Scientific Relations, Alzheimer's Association

Read Heather Snyder 's bio

Dr. Paul Aisen, M.D.

Dr. Paul Aisen, M.D.

Director, Alzheimer's Disease Cooperative Study

Read Dr. Paul Aisen, M.D. 's bio

Dr. Timothy J. Garnett

Dr. Timothy J. Garnett

Chief Medical Officer & SVP, Eli Lilly & Company

Read Dr. Timothy J. Garnett's bio

George Vradenburg, J.D.

George Vradenburg, J.D.

Chairman & Co-founder, USAgainstAlzheimer's

Read George Vradenburg, J.D. 's bio

Dr. Suzanne Corkin, Ph.D.

Dr. Suzanne Corkin, Ph.D.

Professor of Neuroscience, Emerita, Department of Brain and Cognitive Sciences, MIT

Read Dr. Suzanne Corkin, Ph.D. 's bio

Dr. Stevin Zorn, Ph.D.

Dr. Stevin Zorn, Ph.D.

EVP & US Site Head, Neuroscience Research and Development, Lundbeck Research USA

Read Dr. Stevin Zorn, Ph.D. 's bio

Robert Egge

Robert Egge

VP, Public Policy, Alzheimer's Association

Read Robert Egge's bio

Howard Fillit, M.D.

Howard Fillit, M.D.

Executive Director & Chief Science Officer, Alzheimer's Drug Discovery Foundation

Read Howard Fillit, M.D. 's bio